Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
Cohen MH, Williams G, Johnson JR, Duan J, Gobburu J, Rahman A, Benson K, Leighton J, Kim SK, Wood R, Rothmann M, Chen G, U KM, Staten AM, Pazdur R.
Cohen MH, et al. Among authors: u km.
Clin Cancer Res. 2002 May;8(5):935-42.
Clin Cancer Res. 2002.
PMID: 12006504